![]() |
|
|
Vol. 289, Issue 3, 1472-1479, June 1999
Department of Pharmacology, College of Physicians & Surgeons of
Columbia University, New York, New York
We investigated block of the
1Cb subunit of L-type
calcium channels by dihydropyridines (DHPs) in which a permanently
charged or neutral head group was linked to the active DHP moiety by a spacer chain containing ten methylene (
CH2) groups. We
compared the sensitivity of channel modulation by the charged (DHPch)
and neutral (DHPn) forms to specific
1Cb mutations in
domains IIIS5, IIIS6, and IVS6, which had previously been shown to
reduce channel modulation by the neutral DHP (+)-isradipine. The
effects of these mutations were studied on channel block recorded from
polarized (
80 mV) and depolarized (
40 mV) holding potentials (HPs).
We found that channel block by DHPn was markedly reduced at both HPs by
each mutation studied. In contrast, channel block by DHPch was only
modestly reduced by mutations in IIIS6 and IVS6 for block from either
40 mV or
80 mV. Replacement of IIIS5 Thr1061 by Tyr, which
abolished block by DHPn in an HP-independent manner, had little effect
on channel block by DHPch recorded from
40 mV. However, this mutation
markedly reduced DHPch block of currents recorded from a
80 mV HP.
Inhibition of current by DHPch was not markedly use-dependent, in
contrast with block by verapamil, another charged calcium channel
blocker. These results suggest that the presence of a permanently
charged head group restricts the access of the attached DHP moiety to a
subset of interaction residues on the
1C subunit in a
voltage-dependent manner. Furthermore, these restricted interactions
confer distinct functional properties upon the charged DHP molecules.
This article has been cited by other articles:
![]() |
S. Tiwari, Y. Zhang, J. Heller, D. R. Abernethy, and N. M. Soldatov Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel {alpha}1C subunit PNAS, November 7, 2006; 103(45): 17024 - 17029. [Abstract] [Full Text] [PDF] |
||||